Antihypertensive effect of a newly synthesized endothelin antagonist, BQ-123, in a genetic hypertensive model
- 1 January 1993
- journal article
- Published by Elsevier in Life Sciences
- Vol. 52 (8) , 717-724
- https://doi.org/10.1016/0024-3205(93)90233-s
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Analysis of responses to endothelins in isolated porcine blood vessels by using a novel endothelin antagonist, BQ-153Life Sciences, 1992
- Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptorLife Sciences, 1992
- Pressor responses to endothelin-1 in normotensive and spontaneously hypertensive ratsNeurochemistry International, 1991
- Plasma immunoreactive endothelin-1 in experimental malignant hypertension.Hypertension, 1991
- An endothelin receptor (ETA) antagonist isolated from Streptomyces misakiensisBiochemical and Biophysical Research Communications, 1991
- Plasma endothelin levels in hypertension and chronic renal failure.Hypertension, 1990
- Effects of endothelin on the portal vein from spontaneously hypertensive and Wistar Kyoto ratsGeneral Pharmacology: The Vascular System, 1990
- Endothelin sensitivity and receptor binding in the aorta of spontaneously hypertensive ratsJournal Of Hypertension, 1989
- Characteristics of pressor response to endothelin in spontaneously hypertensive and Wistar-Kyoto rats.Hypertension, 1989
- A novel potent vasoconstrictor peptide produced by vascular endothelial cellsNature, 1988